Nikko Asset Management Americas, Inc. Intellia Therapeutics, Inc. Transaction History
Nikko Asset Management Americas, Inc.
- $7.42 Billion
- Q1 2025
A detailed history of Nikko Asset Management Americas, Inc. transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Nikko Asset Management Americas, Inc. holds 2,825,361 shares of NTLA stock, worth $19.4 Million. This represents 0.27% of its overall portfolio holdings.
Number of Shares
2,825,361
Previous 2,992,663
5.59%
Holding current value
$19.4 Million
Previous $34.9 Million
42.43%
% of portfolio
0.27%
Previous 0.39%
Shares
27 transactions
Others Institutions Holding NTLA
# of Institutions
344Shares Held
98.4MCall Options Held
784KPut Options Held
713K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl13MShares$89.4 Million1.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.8MShares$73.9 Million0.0% of portfolio
-
Black Rock Inc. New York, NY9.6MShares$65.9 Million0.0% of portfolio
-
State Street Corp Boston, MA4.51MShares$31 Million0.0% of portfolio
-
Morgan Stanley New York, NY3.8MShares$26.1 Million0.0% of portfolio
About Intellia Therapeutics, Inc.
- Ticker NTLA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,011,800
- Market Cap $522M
- Description
- Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...